Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -246.42% is 156% below its 5-year average of -96.25%, near the low end of its 5-year range (-10472.06%–27208.25%).
104.66% below its 12-month average of 5291.50%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -177.43%.
NET PROFIT MARGIN
-246.42%
NET PROFIT MARGIN AVG TTM
5291.50%
NET PROFIT MARGIN AVG 3Y
-68.25%
NET PROFIT MARGIN AVG 5Y
-96.25%
NET PROFIT MARGIN AVG 10Y
-609.05%
NET PROFIT MARGIN AVG 15Y
-613.48%
NET PROFIT MARGIN AVG 20Y
-883.90%
CURRENT VS TTM AVG
-104.66%
CURRENT VS 3Y AVG
-261.06%
CURRENT VS 5Y AVG
-156.02%
CURRENT VS 10Y AVG
+59.54%
CURRENT VS 15Y AVG
+59.83%
CURRENT VS 20Y AVG
+72.12%
SECTOR MEDIAN · HEALTHCARE
-0.35%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
-70305.71%
vs the sector median at left
Abeona Therapeutics Inc.
Market Cap
$285.55M
Net Profit Margin
-246.42%
TTM Avg
5291.50%
3Y Avg
-68.25%
5Y Avg
-96.25%
Market Cap
$285.42M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-348.45%
5Y Avg
-232.30%
Market Cap
$284.31M
Net Profit Margin
-38.13%
TTM Avg
-18.76%
3Y Avg
-107.01%
5Y Avg
-249.44%
Market Cap
$282.64M
Net Profit Margin
-103.29%
TTM Avg
-83.69%
3Y Avg
-107.92%
5Y Avg
-85.90%
Market Cap
$288.79M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$281.54M
Net Profit Margin
0.00%
TTM Avg
-6.08%
3Y Avg
-1303.66%
5Y Avg
-1073.20%
Market Cap
$280.37M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$292.59M
Net Profit Margin
-145.12%
TTM Avg
-145.12%
3Y Avg
-145.12%
5Y Avg
-145.12%
Market Cap
$293.30M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Abeona Therapeutics Inc. (ABEO) | $285.55M | -246.42% | 5291.50% | -68.25% | -96.25% |
| Sagimet Biosciences Inc. (SGMT)vs › | $285.42M | 0.00% | 0.00% | -348.45% | -232.30% |
| Aurora Cannabis Inc. (ACB)vs › | $284.31M | -38.13% | -18.76% | -107.01% | -249.44% |
| Standard BioTools Inc. (LAB)vs › | $282.64M | -103.29% | -83.69% | -107.92% | -85.90% |
| Larimar Therapeutics, Inc. (LRMR)vs › | $288.79M | 0.00% | 0.00% | 0.00% | 0.00% |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $281.54M | 0.00% | -6.08% | -1303.66% | -1073.20% |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $280.37M | 0.00% | 0.00% | 0.00% | 0.00% |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $292.59M | -145.12% | -145.12% | -145.12% | -145.12% |
| Indaptus Therapeutics, Inc. (INDP)vs › | $293.30M | 0.00% | 0.00% | 0.00% | 0.00% |
| Vanda Pharmaceuticals Inc. (VNDA)vs › | $271.81M | -127.41% | -55.77% | -26.94% | -14.34% |
Operating Margin
-1536.9%
Net Profit Margin
-246.4%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -177.43% |
| 2026-03-31 | -195.81% |
| 2025-12-31 | -377.49% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 27208.25% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | -475.83% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | -10472.06% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | -409.70% |
| 2022-03-31 | -6371.10% |
| 2021-12-31 | -1556.10% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | -527.60% |
| 2020-09-30 | -103.39% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 821.38% |
| 2018-09-30 | -960.74% |
| 2018-06-30 | -4239.13% |
| 2018-03-31 | -1593.79% |
| 2017-12-31 | -3930.23% |
| 2017-09-30 | -2439.73% |
| 2017-06-30 | -3815.21% |
| 2017-03-31 | -2820.97% |
| 2016-12-31 | -2735.16% |
| 2016-09-30 | -1426.09% |
| 2016-06-30 | -3132.24% |
| 2016-03-31 | -2359.15% |
| 2015-12-31 | -1088.37% |
| 2015-09-30 | -2130.88% |
| 2015-06-30 | -1458.51% |
| 2015-03-31 | -775.19% |
| 2014-12-31 | -5103.85% |
| 2014-09-30 | -622.46% |
| 2014-06-30 | -5063.56% |
| 2014-03-31 | -412.98% |
| 2013-12-31 | -663.58% |
| 2013-09-30 | -83.07% |
| 2013-06-30 | 342.61% |
| 2013-03-31 | 333.42% |
| 2012-12-31 | 1970.87% |
| 2012-09-30 | -1706.89% |
| 2012-06-30 | -1536.23% |
| 2012-03-31 | -263.72% |
| 2011-12-31 | 55.53% |
| 2011-09-30 | 33.62% |
| 2011-06-30 | -837.09% |
| 2011-03-31 | -1266.00% |
| 2010-12-31 | 1566.67% |
| 2010-09-30 | -10014.96% |
| 2010-06-30 | 1704.76% |
| 2010-03-31 | 1067.65% |
| 2009-12-31 | -8626.92% |
| 2009-09-30 | -2827.08% |
| 2009-06-30 | -3504.76% |
| 2009-03-31 | -5095.12% |
| 2008-12-31 | -2122.97% |
| 2008-09-30 | -8555.32% |
| 2008-06-30 | -1699.24% |
| 2008-03-31 | -27881.58% |
| 2007-12-31 | -26790.20% |
| 2007-09-30 | -32616.67% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | 0.00% |
| 2006-03-31 | 0.00% |
| 2005-12-31 | -1025.12% |
| 2005-09-30 | -870.89% |
| 2005-06-30 | -1523.69% |
| 2005-03-31 | -1567.74% |
| 2004-12-31 | -1052.90% |
| 2004-09-30 | -1312.43% |
| 2004-06-30 | -3754.41% |
| 2004-03-31 | -11755.00% |
| 2003-12-31 | -1266.35% |
| 2003-09-30 | -20054.55% |
| 2003-06-30 | 46.27% |
| 2003-03-31 | -613.49% |
| 2002-12-31 | -347.42% |
| 2002-09-30 | -3140.66% |
